Update on the Vitamin D and OmegA-3 trial (VITAL)

Journal of Steroid Biochemistry and Molecular Biology

Volumn 155, Issue , 2016, Pages 252-256

  Pradhan, Aruna D ^a,b   Manson, JoAnn E ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer; Cardiovascular disease; Cholecalciferol; Omega 3 fatty acids; Primary prevention; Randomized controlled trial; Vitamin D

Indexed keywords

COLECALCIFEROL; OMEGA 3 ACID ETHYL ESTER; DOCOSAHEXAENOIC ACID; DRUG COMBINATION; ICOSAPENTAENOIC ACID; VITAMIN D;

ADULT; ARTICLE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NEOPLASM; PHENOTYPE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; AGED; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; DRUG COMBINATION; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; RESEARCH; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; RESEARCH REPORT; UNITED STATES; VITAMIN D;

EID: 84949320264     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.04.006     Document Type: Article

References (43)

1. E. Giovannucci, Y. Liu, E.B. Rimm, B.W. Hollis, C.S. Fuchs, M.J. Stampfer, and W.C. Willett Prospective study of predictors of vitamin D status and cancer incidence and mortality in men J. Natl. Cancer Inst. 98 2006 451 459
2. J.M. Ordonez-Mena, B. Schottker, U. Haug, H. Muller, J. Kohrle, L. Schomburg, B. Holleczek, and H. Brenner Serum 25-hydroxyvitamin D and cancer risk in older adults: Results from a large german prospective cohort study Cancer Epidemiol. Biomarkers Prev. 22 2013 905 916
3. I.H. de Boer, G. Levin, C. Robinson-Cohen, M.L. Biggs, A.N. Hoofnagle, D.S. Siscovick, and B. Kestenbaum Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study Ann. Intern. Med. 156 2012 627 634
4. S. Pilz, K. Kienreich, A. Tomaschitz, E. Ritz, E. Lerchbaum, B. Obermayer-Pietsch, V. Matzi, J. Lindenmann, W. Marz, S. Gandini, and J.M. Dekker Vitamin D and cancer mortality: systematic review of prospective epidemiological studies Anti-Cancer Agents Med. Chem. 13 2013 107 117
5. D.P. Trivedi, R. Doll, and K.T. Khaw Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial BMJ 326 2015 469
6. J.M. Lappe, D. Travers-Gustafson, K.M. Davies, R.R. Recker, and R.P. Heaney Vitamin d and calcium supplementation reduces cancer risk: results of a randomized trial Am. J. Clin. Nutr. 85 2007 1586 1591
7. J. Wactawski-Wende, J.M. Kotchen, G.L. Anderson, A.R. Assaf, R.L. Brunner, M.J. O'Sullivan, K.L. Margolis, J.K. Ockene, L. Phillips, L. Pottern, R.L. Prentice, J. Robbins, T.E. Rohan, G.E. Sarto, S. Sharma, M.L. Stefanick, L. Van Horn, R.B. Wallace, E. Whitlock, T. Bassford, S.A. Beresford, H.R. Black, D.E. Bonds, R.G. Brzyski, B. Caan, R.T. Chlebowski, B. Cochrane, C. Garland, M. Gass, J. Hays, G. Heiss, S.L. Hendrix, B.V. Howard, J. Hsia, F.A. Hubbell, R.D. Jackson, K.C. Johnson, H. Judd, C.L. Kooperberg, L.H. Kuller, A.Z. LaCroix, D.S. Lane, R.D. Langer, N.L. Lasser, C.E. Lewis, M.C. Limacher, and J.E. Manson Women's health initiative: calcium plus vitamin D supplementation and the risk of colorectal cancer N. Engl. J. Med. 354 2006 684 696
8. R.T. Chlebowski, K.C. Johnson, C. Kooperberg, M. Pettinger, J. Wactawski-Wende, T. Rohan, J. Rossouw, D. Lane, M.J. O'Sullivan, S. Yasmeen, R.A. Hiatt, J.M. Shikany, M. Vitolins, J. Khandekar, and F.A. Hubbell Women's health initiative I. Calcium plus vitamin D supplementation and the risk of breast cancer J. Natl. Cancer Inst. 100 2008 1581 1591
9. A. Avenell, G.S. MacLennan, D.J. Jenkinson, G.C. McPherson, A.M. McDonald, P.R. Pant, A.M. Grant, M.K. Campbell, F.H. Anderson, C. Cooper, R.M. Francis, W.J. Gillespie, C.M. Robinson, D.J. Torgerson, W.A. Wallace, and RT Group Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD Trial) J. Clin. Endocrinol. Metab. 97 2012 614 622
10. S.A. Beresford, K.C. Johnson, C. Ritenbaugh, N.L. Lasser, L.G. Snetselaar, H.R. Black, G.L. Anderson, A.R. Assaf, T. Bassford, D. Bowen, R.L. Brunner, R.G. Brzyski, B. Caan, R.T. Chlebowski, M. Gass, R.C. Harrigan, J. Hays, D. Heber, G. Heiss, S.L. Hendrix, B.V. Howard, J. Hsia, F.A. Hubbell, R.D. Jackson, J.M. Kotchen, L.H. Kuller, A.Z. LaCroix, D.S. Lane, R.D. Langer, C.E. Lewis, J.E. Manson, K.L. Margolis, Y. Mossavar-Rahmani, J.K. Ockene, L.M. Parker, M.G. Perri, L. Phillips, R.L. Prentice, J. Robbins, J.E. Rossouw, G.E. Sarto, M.L. Stefanick, L. Van Horn, M.Z. Vitolins, J. Wactawski-Wende, R.B. Wallace, and E. Whitlock Low-fat dietary pattern and risk of colorectal cancer: the women's health initiative randomized controlled dietary modification trial JAMA 295 2006 643 654
11. Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D 2011 The National Academies Press Washington, DC
12. R.L. Prince, N. Austin, A. Devine, I.M. Dick, D. Bruce, and K. Zhu Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women Arch. Intern. Med. 168 2008 103 108
13. L. Wang, J.E. Manson, Y. Song, and H.D. Sesso Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events Ann. Intern. Med. 152 2010 315 323
14. J. Hsia, G. Heiss, H. Ren, M. Allison, N.C. Dolan, P. Greenland, S.R. Heckbert, K.C. Johnson, J.E. Manson, S. Sidney, and M. Trevisan Calcium/vitamin D supplementation and cardiovascular events Circulation 115 2007 846 854
15. A.Z. LaCroix, J. Kotchen, G. Anderson, R. Brzyski, J.A. Cauley, S.R. Cummings, M. Gass, K.C. Johnson, M. Ko, J. Larson, J.E. Manson, M.L. Stefanick, and J. Wactawski-Wende Calcium plus vitamin d supplementation and mortality in postmenopausal women: the women's health initiative calcium-vitamin D randomized controlled trial J. Gerontol. A: Biol. Sci. Med. Sci. 64 2009 559 567
16. M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, and V.M. Montori Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis J. Clin. Endocrinol. Metab. 96 2011 1931 1942
17. M. Gerber Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies Br. J. Nutr. 107 Suppl (2) 2012 S228 239
18. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n - 3 polyunsaturated fatty acids and vitamin e after myocardial infarction: results of the gissi-prevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico Lancet 354 1999 447 455
19. M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, T. Kita, A. Kitabatake, N. Nakaya, T. Sakata, K. Shimada, and K. Shirato Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
20. GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the gissi-hf trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1223 1230
21. M.C. Roncaglioni, M. Tombesi, F. Avanzini, S. Barlera, V. Caimi, P. Longoni, I. Marzona, V. Milani, M.G. Silletta, G. Tognoni, and R. Marchioli N - 3 fatty acids in patients with multiple cardiovascular risk factors N. Engl. J. Med. 368 2013 1800 1808
22. J. Bosch, H.C. Gerstein, G.R. Dagenais, R. Diaz, L. Dyal, H. Jung, A.P. Maggiono, J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Ryden, and S. Yusuf N - 3 fatty acids and cardiovascular outcomes in patients with dysglycemia N. Engl. J. Med. 367 2012 309 318
23. D. Kromhout, E.J. Giltay, J.M. Geleijnse, and Alpha Omega Trial Group N - 3 fatty acids and cardiovascular events after myocardial infarction N. Engl. J. Med. 363 2010 2015 2026
24. V.A. Andreeva, M. Touvier, E. Kesse-Guyot, C. Julia, P. Galan, and S. Hercberg B vitamin and/or omega-3 fatty acid supplementation and cancer: Ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial Arch. Intern. Med. 172 2012 540 547
25. P. Galan, E. Kesse-Guyot, S. Czernichow, S. Briancon, J. Blacher, and S. Hercberg Effects of b vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial BMJ 341 2010 c6273
26. B. Rauch, R. Schiele, S. Schneider, F. Diller, N. Victor, H. Gohlke, M. Gottwik, G. Steinbeck, U. Del Castillo, R. Sack, H. Worth, H. Katus, W. Spitzer, G. Sabin, and J. Senges Omega, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
27. S.R. Eussen, J.M. Geleijnse, E.J. Giltay, C.J. Rompelberg, O.H. Klungel, and D. Kromhout Effects of n - 3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction Eur. Heart J. 33 2012 1582 1588
28. R. Marchioli, R.M. Marfisi, G. Borrelli, C. Chieffo, M.G. Franzosi, G. Levantesi, A.P. Maggioni, G.L. Nicolosi, M. Scarano, M.G. Silletta, C. Schweiger, L. Tavazzi, and G. Tognoni Efficacy of n - 3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the gissi-prevenzione trial J. Cardiovasc. Med. 8 Suppl (1) 2007 S34 37
29. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis JAMA 308 2012 1024 1033
30. C. Vlachopoulos, D. Richter, and C. Stefanadis Omega-3 fatty acid supplementation and cardiovascular disease events JAMA 309 2013 28
31. W.S. Harris Are n-3 fatty acids still cardioprotective? Curr. Opin. Clin. Nutr. Metab. Care 16 2013 141 149
32. R. Neale, D-Health Trial Australian New Zealand Clinical Trials Registry identifier: ACTRN12613000743763. Available at: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364534&isClinicalTrial=False. (accessed 11.09.14).
33. T-P. Toumainen, Finnish Vitamin D Trial (FIND). ClinicalTrials.gov identifier: NCT01463813. Available at: http://www.clinicaltrials.gov/ct2/show/NCT01463813?intr=vitamin+D&outc=cancer&rank=10 (accessed 11.09.14).
34. J. Peto, Vitamin D and Longevity (VIDAL) Trial: Randomised Feasibility Study. ISRCTN46328341. Available at: http://www.controlled-trials.com/ISRCTN46328341 (accessed 11.09.14).
35. B.W. Hollis, and C.L. Wagner The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes J. Clin. Endocrinol. Metab. 2013
36. R. Scragg, C.A. Camargo, Vitamin D Assessment (VIDA) trial. Australia new zealand clinical trials registry identifier: Actrn12611000402943. Available at: https://http://www.Anzctr.Org.Au/trial/registration/trialreview.Aspx?Id=336777. (accessed 10.09.14).
37. K. Amrein, S.A. Quraishi, A.A. Litonjua, F.K. Gibbons, T.R. Pieber, C.A. Camargo Jr., E. Giovannucci, and K.B. Christopher Evidence for a u-shaped relationship between prehospital vitamin D status and mortality: a cohort study J. Clin. Endocrinol. Metab. 99 2014 1461 1469
38. M.P. Akhter, J.M. Lappe, K.M. Davies, and R.R. Recker Transmenopausal changes in the trabecular bone structure Bone 41 2007 111 116
39. Bischoff-Ferrari HA. DO-HEALTH / vitamin d3 - omega3 - home exercise - healthy ageing and longevity trial. Clinicaltrials.Gov identifier: Nct01745263. Available at: http://www.Clinicaltrials.Gov/ct2/show/nct01745263?Term=nct01745263&rank=1 (accessed 10.09.14).
40. Baron JA. Vitamin d/calcium polyp prevention study. Clinicaltrials.Gov identifier: NCT00153816. Available at: http://www.Clinicaltrials.Gov/ct2/show/nct00153816?Id=nct00153816&rank=1 (accessed 10.09.14).
41. ASCEND Investigators Ascend (a study of cardiovascular events in diabetes) website. Available at: http://www.Ctsu.Ox.Ac.Uk/ascend/ (accessed 10.09.14).
42. J.E. Manson, S.S. Bassuk, I.M. Lee, N.R. Cook, M.A. Albert, D. Gordon, E. Zaharris, J.G. Macfadyen, E. Danielson, J. Lin, S.M. Zhang, and J.E. Buring The vitamin D and omega-3 trial (vital): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease Contemp. Clin. Trials 33 2012 159 171
43. P.M. Ridker, N.R. Cook, I.M. Lee, D. Gordon, J.M. Gaziano, J.E. Manson, C.H. Hennekens, and J.E. Buring A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N. Engl. J. Med. 352 2005 1293 1304